Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marco Bussetti"'
Autor:
Vincenzo Roccaforte, Flavia Sciarini, Vanessa Proserpio, Ruggero Buonocore, Emanuela Marina Zavaroni, Silvia Burati, Marco Bussetti, Giammaria Liuzzi, Rosalba Monica Russo, Wanda Patrizia Porreca, Maria Luisa De Angelis, Carlo Federico Perno, Claudio Bonato, Stefano Pastori
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 147-155 (2021)
Objectives: The purpose of this study was to compare data obtained from the reticulocyte channel (RET channel) heated to 41 °C with those obtained from impedance channel (I-Channel) at room temperature in the samples with the mean corpuscular hemogl
Externí odkaz:
https://doaj.org/article/c28f1aeb84df4cdc89d210d48ddc0ff8
Autor:
Simona Ferraro, Davide Biganzoli, Roberta Simona Rossi, Franco Palmisano, Marco Bussetti, Enrica Verzotti, Andrea Gregori, Filippo Bianchi, Marco Maggioni, Ferruccio Ceriotti, Cristina Cereda, Gianvincenzo Zuccotti, Peter Kavsak, Mario Plebani, Giuseppe Marano, Elia Mario Biganzoli
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:1327-1334
Objectives Clinical practice guidelines endorse the stratification of prostate cancer (PCa) risk according to individual total prostate-specific antigen (tPSA) values and age to enhance the individual risk-benefit ratio. We defined two nomograms to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::140d8f668f4452f1accbe99729cbd0e2
https://doi.org/10.1515/cclm-2023-0008
https://doi.org/10.1515/cclm-2023-0008
Autor:
Simona Ferraro, Giacomo Biganzoli, Marco Bussetti, Silvana Castaldi, Elia Mario Biganzoli, Mario Plebani
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:142-153
Objectives We assessed the inter-method bias of total (tPSA) and free (fPSA) prostate-specific antigen (PSA) immunoassays to establish if tPSA-based risk thresholds for advanced prostate cancer (PCa), obtained from one method (Roche) can be converted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113e994e6f9bf200e07edf5781f542b3
https://doi.org/10.1515/cclm-2022-0874
https://doi.org/10.1515/cclm-2022-0874
Publikováno v:
Clinica Chimica Acta. 516:77-82
Background and aims We investigated factors influencing pre-biopsy prostate-specific antigen (PSA) retesting as recommended by clinical guidelines. Materials and methods 333 patients screened for prostate cancer (PCa) repeated PSA (Roche Cobas system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf936e71f6afed3e8abcf73de0540ef5
https://doi.org/10.1016/j.cca.2021.01.017
https://doi.org/10.1016/j.cca.2021.01.017
Publikováno v:
Clinical Chemistry. 67:543-553
Background Previous studies have shown that the harmonization of prostate-specific antigen (PSA) assays remained limited even after the introduction of WHO International Standards. This information needs updating for current measuring systems (MS) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749e5c58c130e7c68c9d6c9966ebfb80
https://doi.org/10.1093/clinchem/hvaa268
https://doi.org/10.1093/clinchem/hvaa268
Publikováno v:
Clinical Chemistry. 67:602-609
Background Current clinical practice guidelines (CPGs) for early detection of prostate cancer recommend for clinical decision-making a personalized prostate-specific antigen (PSA)-based management to improve the risk-benefit ratio of the screening st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294f51e54aa814fa4407c90781da56a4
https://doi.org/10.1093/clinchem/hvab002
https://doi.org/10.1093/clinchem/hvab002
Autor:
Simona Ferraro, Marco Bussetti, Niccolò Bassani, Roberta Simona Rossi, Giacomo Piero Incarbone, Filippo Bianchi, Marco Maggioni, Letterio Runza, Ferruccio Ceriotti, Mauro Panteghini
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3381, p 3381 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3381, p 3381 (2021)
We defined prostate-specific antigen (PSA) thresholds from a well calibrated risk prediction model for identifying and excluding advanced prostate cancer (PCa). We retrieved 902 biopsied patients with a pre-biopsy PSA determination (Roche assay). A l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6c28dc57b4a1434137b4d7ab71e29f75
http://europepmc.org/articles/PMC8305281
http://europepmc.org/articles/PMC8305281
Autor:
Silvia Burati, Massimo Daves, Carlo Federico Perno, Maria Luisa De Angelis, Marco Bussetti, Ruggero Buonocore, Rosalba Monica Russo, Roberto Cemin, Fabrizio Cappellini, Paolo Brambilla, Giammaria Liuzzi, Stefano Pastori, Vincenzo Roccaforte, Marta Cecilia Tosca, Wanda Patrizia Porreca
Publikováno v:
La Rivista Italiana della Medicina di Laboratorio. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22cba7cca45237585260a2b3736948d8
https://doi.org/10.23736/s1825-859x.20.00050-x
https://doi.org/10.23736/s1825-859x.20.00050-x
Autor:
Rosanna Falbo, Maria Roberta Sala, Paolo Brambilla, C. Giacobone, Chiara Fania, Marco Bussetti, Fabrizio Cappellini
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 491
The use of phase contrast in urinalysis has been highly recommended. A new system, sediMAX conTRUST PRO, is now available providing simultaneous automated phase contrast and bright field microscopy. This study aimed to evaluate both analytical and di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c203299121e1dd4be6e2eaf4aa170174
https://pubmed.ncbi.nlm.nih.gov/30703345
https://pubmed.ncbi.nlm.nih.gov/30703345
Autor:
Marco Bussetti, O. Lorenz, J. Song, G. Van Causbroeck, Rosanna Falbo, C. Giacobone, Soohyoung Kim, A. Von Meyer, I. Brandt, K. Klopprogge, P. Metz
Publikováno v:
Clinica Chimica Acta. 493:S61-S62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df1a4adb6042841a63bf6559c963dee7
https://doi.org/10.1016/j.cca.2019.03.137
https://doi.org/10.1016/j.cca.2019.03.137